Brief: Aptose Announces FDA Allowance Of Investigational New Drug Application For CG-806

Aptose Biosciences

25/03/2019 11:10

March 25 (Reuters) - Aptose Biosciences Inc  APS.TO :
    * APTOSE ANNOUNCES FDA ALLOWANCE OF INVESTIGATIONAL NEW DRUG
APPLICATION FOR CG-806
    * APTOSE BIOSCIENCES INC - PHASE 1 TRIAL IN RELAPSED OR
REFRACTORY
CLL AND B CELL MALIGNANCIES PLANNED TO INITIATE IN Q2/2019

Source text for Eikon:  ID:nGNX6gFwK8 
Further company coverage:  APS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))